Biaya Tersembunyi di Balik Malaria: Studi Baru Ungkap Besarnya Beban Ekonomi bagi Masyarakat Desa
Jatuh sakit dengan malaria menguras biaya yang jauh lebih besar dibandingkan penyakit demam lainnya karena hilangnya waktu untuk bekerja dan menjalani rutinitas. Studi yang terbit di BMJ Global Health ini merupakan penelitian pertama yang mengukur secara sistematis beban ekonomi dari malaria, termasuk kasus malaria zoonosis, di daerah pedesaan dan terpencil di Indonesia. Riset yang merupakan […]
The Hidden Costs of Malaria: New Study Reveals Higher Economic Burden on Rural Families
Being sick with malaria costs significantly more than other febrile illnesses, mostly due to time lost from work and daily routines. While health inequalities are a known reality, a recent paper published in BMJ Global Health marks the first time these hidden economic costs, particularly for zoonotic malaria, have been systematically measured across rural and […]
Indonesia Minister of Health Aims to Scale SPHERES Initiative Nationwide Following High-Level Visit
PURBALINGGA, March 10, 2026 – During a high-profile visit to the SPHERES project site in Purbalingga, Central Java, Indonesia’s Minister of Health, Budi Gunadi Sadikin, lauded the project’s progress and set an ambitious target for its national expansion. “I see that the project is excellent. I hope it can serve as a model to be implemented in all 514 districts and cities across […]
Menkes Targetkan Perluasan Inisiatif SPHERES Secara Nasional Setelah Kunjungan Kerja
PURBALINGGA, 10 Maret, 2026 – Saat melakukan kunjungan kerja ke lokasi proyek SPHERES di Purbalingga, Jawa Tengah, Menteri Kesehatan Indonesia, Budi Gunadi Sadikin, memuji progres proyek tersebut dan menetapkan target ambisius untuk perluasannya ke tingkat nasional. “Saya melihat bagus sekali [progresnya]. Mudah-mudahan nanti bisa menjadi contoh untuk diimplementasikan di 514 kab/kota di seluruh Indonesia,” ujar […]
Pekerja Pabrik yang Menjadi Ilmuwan Penyakit Menular: Kisah Suwarti dari OUCRU Indonesia
Suwarti adalah seorang ilmuwan laboratorium klinis di OUCRU Indonesia. Pekerjaanya meliputi mendeteksi keberadaan penyakit, melacak evolusi patogen, dan mempelajari reaksi tubuh terhadap infeksi. Selama tujuh tahun bekerja di OUCRU Indonesia, Suwarti telah memberikan banyak sumbangsih terhadap berbagai studi penting, termasuk studi-studi tentang Covid-19 dan kesiapsiagaan pandemi secara umum. Risetnya belakangan ini berfokus pada mempelajari reaksi […]
From Factory Worker to Infectious Diseases Scientist: The Story of OUCRU Indonesia’s Suwarti
Suwarti is a scientist at OUCRU Indonesia who specialises in clinical laboratory research. Her work involves detecting diseases, tracking how pathogens evolve, and studying how the human body responds to infections. Over the past seven years, Suwarti has been a key contributor to many major research projects, including the unit’s critical work on Covid-19 and […]
OUCRU & the Hospital for Tropical Diseases: 35 years of partnership.Â
From our earliest malaria trials in 1991 to today’s shared work on many infectious diseases, we mark 35 years of partnership with the Hospital for Tropical Diseases (HTD), HCMC. This year, Oxford University Clinical Research Unit (OUCRU) marks 35 years since its establishment in Vietnam (26 January 1991 – 26 January 2026). The anniversary also recognises 35 years of partnership with the […]
First MODRA cohort graduates
The first cohort of the MORU–OUCRU Discovery Research Academy, MODRA, has officially graduated following a final four-day workshop held in December 2025 in Sanur, Bali. The workshop marked the conclusion of the programme’s inaugural 18-month cycle and brought together 15 early to mid-career researchers from across South and Southeast Asia to present their research, reflect […]
No Survival Benefit from High-Dose Rifampicin in Tuberculous Meningitis, Major Global Trial FindsÂ
A major international clinical trial, known as the HARVEST trial, has found that giving a higher dose of rifampicin does not improve survival in adults with tuberculous meningitis, the most severe and deadly form of tuberculosis. Tuberculous meningitis affects the brain and spinal cord and remains extremely difficult to treat. Up to half of patients die despite […]
Study Finds COVID-19 Vaccine Boosters Still Protect Vulnerable Indonesians Well Into the Post-Pandemic PeriodÂ
COVID-19 vaccine booster shots made from the original strain of the virus still save lives among vulnerable Indonesians, but provide limited protection for the wider public, according to a new study by OUCRU Indonesia, Universitas Gadjah Mada, and the U.S. Centers for Disease Control and Prevention. These vaccines were developed based on the original SARS-CoV-2 […]
WHO Luncurkan Laporan Resistensi Antimikroba Sedunia: Intisari dan Kontribusi OUCRU
WHO baru saja menerbitkan Global Antimicrobial Resistance and Use Surveillance (GLASS) Report edisi terbaru. Laporan 2025 ini memberikan gambaran paling lengkap dan terkini tentang situasi resistensi antimikroba (AMR) di seluruh dunia, berdasarkan data dari 104 negara. GLASS adalah sistem global yang memantau bagaimana kuman bereaksi terhadap antibiotik dan bagaimana negara-negara memperkuat kemampuannya dalam mengawasi AMR. […]
WHO Releases New Global Antimicrobial Resistance Surveillance Report: Highlights and OUCRU’s ContributionÂ
WHO released its latest Global Antimicrobial Resistance and Use Surveillance (GLASS) Report last week, with new findings on antimicrobial resistance (AMR) around the world. The 2025 report draws on data from 104 countries and presents the most complete and up-to-date global picture of AMR to date. GLASS is a global system for tracking how pathogens […]
Indonesia to Host First Dual-Species Malaria Vaccination Trial
OUCRU Indonesia is preparing a Phase 2 clinical trial of a malaria vaccination designed to protect against the two most widespread malaria parasites, Plasmodium falciparum and Plasmodium vivax. The trial, to be conducted in Keerom, Papua, will be the first to test a dual-species malaria vaccination in humans. The trial will test two vaccines developed […]
Indonesia Akan Menggelar Uji Vaksinasi Malaria Dwispesies Pertama di Dunia
OUCRU Indonesia sedang mempersiapkan uji klinis Fase 2 untuk vaksinasi yang bisa melindungi dari dua parasit malaria yang paling umum, Plasmodium falciparum dan Plasmodium vivax. Uji coba yang akan dilakukan di Keerom, Papua, ini akan menjadi uji vaksinasi pertama pada manusia untuk dua jenis malaria sekaligus. Uji klinis ini menggunakan dua vaksin yang dikembangkan oleh […]
Ikuti Kursus Daring Penyakit Tropis Terabaikan WHO dalam Bahasa Indonesia
Bekerja sama dengan Organisasi Kesehatan Dunia (WHO) dan Universitas Gadjah Mada, OUCRU Indonesia telah menerjemahkan enam kursus WHO tentang Penyakit Tropis Terabaikan (NTD) ke dalam bahasa Indonesia. Kursus daring gratis ini dirancang untuk tenaga kesehatan (nakes) guna meningkatkan kesadaran dan pengetahuan mereka dalam menangani NTD kulit. Topiknya mencakupi kudis, frambusia, mycetoma, dermatologi tropis, kromoblastomikosis, dan […]
Klorokuin dan Hidroksiklorokuin Punya Efek Moderat Cegah COVID-19, Ungkap Riset Klinis Besar
12 Desember 2024 – Uji klinis baru menunjukkan bahwa klorokuin dan hidroksiklorokuin memberikan perlindungan moderat terhadap virus Covid-19. Para partisipan riset yang meminum klorokuin (CQ) atau hidroksiklorokuin (HCQ) punya risiko terinfeksi Covid-19 bergejala 15% lebih rendah dibandingkan kelompok plasebo. Melibatkan lebih dari 4.600 sukarelawan, uji klinis ini merupakan studi terbesar di dunia tentang manfaat kedua […]
Chloroquine and Hydroxychloroquine Show Moderate Effect in Preventing COVID-19, New Large Clinical Trial Shows
12 December 2024 – The world’s largest study on the use of hydroxychloroquine (HCQ) and chloroquine (CQ) to prevent COVID-19 has published results showing moderate protection against the virus. The trial involved over 4,600 participants and found a 15% reduction in symptomatic COVID-19 among those who took the medications compared to those who took a […]
OUCRU researchers help shape global priorities in AMR researchÂ
OUCRU researchers from Indonesia, Nepal, and Vietnam contributed to the newly published WHO research priorities for AMR. These top 40 priorities, developed by the World Health Organization (WHO) with global collaborators, aim to guide research into drug-resistant infections over the next five years, with a special focus on challenges faced by low- and middle-income countries […]
Peneliti OUCRU Turut Susun Agenda Riset AMR Dunia
Peneliti OUCRU dari Indonesia, Nepal, dan Vietnam ambil andil dalam penyusunan agenda riset AMR yang baru diterbitkan oleh WHO. Empat puluh topik penelitian prioritas ditentukan bersama berbagai kolaborator dari seluruh dunia untuk memandu riset tentang mikroba resisten obat selama lima tahun ke depan. Perhatian khusus diberikan terhadap tantangan-tantangan yang kerap dihadapi negara berpendapatan rendah dan […]
OUCRU góp phần xác định ưu tiên nghiên cứu toà n cầu vỠkháng thuốc kháng sinh
Các nhà nghiên cứu OUCRU từ Indonesia, Nepal và Việt Nam đã góp phần xây dá»±ng danh sách các Æ°u tiên nghiên cứu vá» kháng thuốc (AMR) má»›i được Tổ chức Y tế Thế giá»›i (WHO) công bố. Danh sách 40 Æ°u tiên nà y được phát triển cùng vá»›i các đối tác toà n cầu, nhằm […]